Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes

A.C. Jeannin, J.E. Salem, Z. Massy, C.E. Aubert, C. Vemeer, C. Amouyal, F. Phan, M. Halbron, C. Funck-Brentano, A. Hartemann, O. Bourron

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Web of Science)
Original languageEnglish
Article number0229145
Number of pages13
JournalPLOS ONE
Volume15
Issue number2
DOIs
Publication statusPublished - 24 Feb 2020

Keywords

  • alpha
  • bone morphogenetic protein-2
  • cardiovascular risk
  • criteria
  • diagnosis
  • inhibition
  • nerve-conduction
  • prevalence
  • receptor
  • risk-factors
  • CRITERIA
  • DIAGNOSIS
  • RISK-FACTORS
  • BONE MORPHOGENETIC PROTEIN-2
  • RECEPTOR
  • ALPHA
  • PREVALENCE
  • NERVE-CONDUCTION
  • INHIBITION
  • CARDIOVASCULAR RISK

Cite this